|1.||Jeschke, Jana: 2 articles (08/2015 - 06/2013)|
|2.||Van Neste, Leander: 2 articles (08/2015 - 06/2013)|
|3.||Ahuja, Nita: 2 articles (08/2015 - 06/2013)|
|4.||Herman, James G: 2 articles (08/2015 - 06/2013)|
|5.||Kim, Myoung Sook: 2 articles (01/2014 - 01/2012)|
|6.||Yamashita, Keishi: 2 articles (01/2014 - 01/2012)|
|7.||Sidransky, David: 2 articles (01/2014 - 01/2012)|
|8.||Lee, Hae Won: 1 article (09/2015)|
|9.||Park, Jong Ho: 1 article (09/2015)|
|10.||Kang, Moon Chul: 1 article (09/2015)|
01/01/2015 - "In particular, cysteine dioxygenase (CDO) has been recognized as a potential marker in oncology due to its altered gene expression in various cancer types. "
01/01/2012 - "Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers."
01/01/2000 - "A panel of four commercially available tumor-derived human brain cell lines, each representing one major class of brain cell, were screened using western blotting and activity assay for cysteine dioxygenase expression. "
09/01/2015 - "Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma."
01/01/2014 - "Altered cysteine dioxygenase 1 (CDO1) gene expression has been observed in several cancers but has not yet been investigated in liposarcomas. "
|2.||Breast Neoplasms (Breast Cancer)
08/01/2015 - "Promoter CpG island methylation of cysteine dioxygenase type 1 (CDO1), which was identified as prognostic marker for breast cancer, is studied as a potential marker for ccRCC survival. "
06/15/2013 - "Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines."
06/15/2013 - "To study mechanisms of cysteine dioxygenase type 1 (CDO1) inactivation and its functional significance in breast cancer in a comprehensive manner, we screened for DNA methylation and gene mutations in primary breast cancers and analyzed growth, survival, and reactive oxygen species (ROS) production in breast cancer cells with restored CDO1 function in the context of anthracycline treatment. "
10/15/2003 - "Functional characterization and regulation of the taurine transporter and cysteine dioxygenase in human hepatoblastoma HepG2 cells."
10/15/2003 - "We investigated the characterization and the regulation of TAUT (taurine transporter) and CDO (cysteine dioxygenase), one of the key enzymes of taurine biosynthesis, in human hepatoblastoma HepG2 cells. "
|4.||Colorectal Neoplasms (Colorectal Cancer)
|5.||Mental Retardation (Idiocy)
|1.||Reactive Oxygen Species (Oxygen Radicals)
|8.||Cystathionine gamma-Lyase (Cysteine Desulfhydrase)
|9.||Aspartate Aminotransferases (Aspartate Transaminase)